Home/Filings/4/0001013596-15-000003
4//SEC Filing

Sunshine Biopharma, Inc 4

Accession 0001013596-15-000003

$SBFMCIK 0001402328operating

Filed

May 31, 8:00 PM ET

Accepted

Jun 1, 8:26 PM ET

Size

4.6 KB

Accession

0001013596-15-000003

Insider Transaction Report

Form 4
Period: 2015-05-27
Slilaty Steve N.
DirectorCEO and President10% Owner
Transactions
  • Purchase

    Series "B" Preferred Stock

    2015-05-27$0.10/sh+500,000$50,000500,000 total

Issuer

Sunshine Biopharma, Inc

CIK 0001402328

Entity typeoperating
IncorporatedCO

Related Parties

1
  • filerCIK 0001402328

Filing Metadata

Form type
4
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 8:26 PM ET
Size
4.6 KB